REGISTERED
on 26 Jun 2018
Last Applicant/ Owned by
38 Sidney Street
Cambridge
MA
02139
Serial Number
87614513 filed on 19th Sep 2017
Registration Number
5504894 registered on 26th Jun 2018
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
RHEOS
Biomedical, pharmaceutical and scientific research in the field of autoimmunity and oncology; pharmaceutical drug services, namely, pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; product development in the field of autoimmunity and oncology; research and development of human therapeutics using cellular harnessing
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Biomedical, pharmaceutical and scientific research in the field of autoimmunity and oncology; pharmaceutical drug services, namely, pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; product development in the field of autoimmunity and oncology; research and development of human therapeutics using cellular harnessing
First Use Date in General
22nd Mar 2018
First Use Date in Commerce
22nd Mar 2018
Mark Details
Serial Number
No 87614513
Mark Type
No Service Mark
Attorney Docket Number
No R080620000US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Jun 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 25th Jan 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 25th Jan 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 19th Jul 2018 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 19th Jul 2018 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 26th Jun 2018 | REGISTERED-PRINCIPAL REGISTER |
| 22nd May 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 21st May 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 03rd May 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 03rd May 2018 | STATEMENT OF USE PROCESSING COMPLETE |